Patients with migraine or e, a pathological condition of nervous system.
Conditions
Interventions
Of the 63 people summoned to the meeting, 43 people attended and agreed to the terms of participation (Informed Consent Form). Of this total, 2 people started the first stage of treatment, but were ex
Device
E02.594.540
Sponsors
Universidade de Araraquara
Universidade de Araraquara
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Only participants who meet the criteria required by the International Headache Society for migraine-type headache (CLASS. SIC, 2014); age over 18 years and above 80 years; complain of headache for more than six months and recurrent episodes; report 3 episodes of migraine per month; reported onset of migraine before age 50; have at least 3 months of history and 2-8 attacks per month, with progression of moderate to severe pain symptoms lasting more than 2h; report headache medication use 14 days / month within 3 months prior to study; If they use migraine prophylaxis, you should be stable for 30 days before and throughout the study.
Exclusion criteria
Exclusion criteria: Users of cardiac pacemakers, history of epilepsy, cardiac arrhythmias, being in gestational period; scheduled or undergoing surgical procedures during treatment or 20 days prior to the start of the study; have other primary headache conditions with 15 or more days of pain per month; use opioids for more than 10 days within 30 days prior to screening; have systemic disease or neurological or psychiatric condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of headache intensity, presence of triggers, pain sites or other factors during migraine occurrence, verified by pain diary before, during and after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess migraine-related disability with the Migraine Disability Assessment Program (MIDAS) Questionnaire (FRAGOSO, 2002) at the end of treatment.;To evaluate the presence and severity of allodynia through the 12 - Item Allodynia Symptom Checklist (ASC - 12) - Brazilian Version (FLORENCE et al., 2012) at the end of treatment.;To assess patient satisfaction and change perception regarding their disease condition by the Global Patient Impression Scale (PGIC) (HURST; BOLTON, 2004) at the end of treatment.;Changes in the level of oxidative stress (Superoxide dismutase - SOD, Catalase, TIOIS) and nitrosative stress (nitrite and nitrate) in the blood before and after treatment. | — |
Countries
Brazil
Contacts
Public ContactNivaldo;Nivaldo Parizotto;Parizotto
Universidade de Araraquara;Universidade de Araraquara
Outcome results
None listed